Evaluation of CYP450 inhibitory effects and steady-state pharmacokinetics of genistein in combination with cholecalciferol and citrated zinc bisglycinate in postmenopausal women.

TitleEvaluation of CYP450 inhibitory effects and steady-state pharmacokinetics of genistein in combination with cholecalciferol and citrated zinc bisglycinate in postmenopausal women.
Publication TypeJournal Article
JournalInternational journal of women's health
Volume3
Pagination139-50
Date Published2011
Abstract

The combination of genistein 27 mg, cholecalciferol 200 IU, citrated zinc bisglycinate (4 mg elemental zinc) 20 mg per capsule in Fosteum(®), a prescription medical food regulated by the FDA and indicated for the dietary management of osteopenia and osteoporosis, was tested for drug interactions and to determine the pharmacokinetic profile for genistein, the principal bone-modulating ingredient in the product.

URLhttp://dx.doi.org/10.2147/IJWH.S19309
DOI10.2147/IJWH.S19309
Short TitleInt J Womens Health
X
Enter your linkblue username.
Enter your linkblue password.
Secure Login

This login is SSL protected

Loading